Pages that link to "Q35959917"

The following pages link to Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines (Q35959917):

Displaying 17 items.

• Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo (Q33865244) (← links)
• Potential roles of DNA methylation in the initiation and establishment of replicative senescence revealed by array-based methylome and transcriptome analyses (Q36269849) (← links)
• MeCP2 and CTCF: enhancing the cross-talk of silencers (Q45303510) (← links)
• MicroRNA in Glioblastoma: An Overview (Q47142132) (← links)
• MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components (Q47552580) (← links)
• Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study (Q47713155) (← links)
• Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma initiating cells. (Q47874491) (← links)
• Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation (Q50147073) (← links)
• Epigenetics and MicroRNAs in Cancer (Q51770872) (← links)
• miR-181a/b therapy in lung cancer: reality or myth? (Q60921827) (← links)
• Developing in 3D: the role of CTCF in cell differentiation (Q88137459) (← links)
• Epigenetic Control of a Local Chromatin Landscape (Q89550961) (← links)
• The use of cannabis in supportive care and treatment of brain tumor (Q92446152) (← links)
• The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target (Q92889047) (← links)
• Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer (Q93007741) (← links)
• miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets (Q100430026) (← links)
• RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway (Q100761796) (← links)